Category Archives: Medicine policy

A medical food for depression?

Neurofolin® (containing 15 mg of L-methylfolate calcium) is a self-declared food for special medical purposes promoted for dietary support of depression management. Advertisments claim that L-methylfolate is, “an active form of folate known to be deficient in individuals with depressive … Continue reading

Posted in Advertising, Complementary medicine, Food, Medicine policy | Tagged | Leave a comment

Traditional Chinese Medicine in Australia: Yunnan Baiyao

An illustrative example of products available in Australia from local Chinese outlets. Illegally supplied (no ARTG number), a potentially dangerous ingredient (Aconiti Kusnezoffii Radix), claims that breach numerous section of the Therapeutic Goods Advertising Code (No.2) 2018 (including promoting for … Continue reading

Posted in Complementary medicine, Medicine policy, Natural Therapies | Tagged , , , , , | Leave a comment

Food-medicine interface problems

FSANZ, Consumer and Public Health Dialogue, 27 March 2019, Canberra. I’ve now provided a report of my presentation and the discussion that ensured. Summary The regulation of health claims for foods and complementary medicines is inconsistent; complaint systems are problematic, … Continue reading

Posted in Advertising, Complementary medicine, Food, Medical Devices, Medicine policy, Pharmaceutical Promotion | Tagged , , , | Leave a comment

Forthcoming SBS Insight program on Vitamins and Supplements

I spent 3 hours with a very pro-supplement audience, being filmed by SBS last night (6/02/2019) . I was surprised by the number of ‘true believers’. I give talks on complementary medicines to U3A classes but I have never found … Continue reading

Posted in Advertising, Complementary medicine, Education, Medicine policy | Tagged , , , , , , , | Leave a comment

TGA’s first comprehensive consumer survey: Results on complementary medicines

During June and July 2018 the Therapeutic Goods Administration (TGA) conducted a survey of Australian adults. It employed a dual sampling methodology: a quota driven population-based sample (Panel) and an Opt-in sample sourced through known TGA contacts, networks and consumer … Continue reading

Posted in Complementary medicine, Education, Medicine policy | Tagged , , , | Leave a comment

Made in Australia? Complementary Medicine Taskforce established; FOI report requested

On 3 December 2018 the Federal Court ruled that encapsulation in Australia of imported fish oil (from Chile) and Vitamin D (from China) did not qualify for the ‘Made in Australia’ logo. The ACCC welcomed the Federal Court ruling that … Continue reading

Posted in Advertising, Chiropractic, Medicine policy | Tagged , , , , , , , , , , , , , , | Leave a comment

40 Years of Antibiotic Guidelines Anniversary Seminar, 13 November, 2018

Program: 40 Years of Antibiotic Guidelines Anniversary Seminar Event Chair: Dr Liz Marles, Chair, Board of Directors of Therapeutic Guidelines Ltd. Speakers: Fighting Antibiotic Resistance in Melbourne Hospitals  Associate Professor Ken Harvey, School of Public Health and Preventive Medicine, Monash University Surviving Antibiotic expert … Continue reading

Posted in Advertising, Education, Medicine policy | Tagged , , , | Leave a comment

Therapeutic Goods Advertising Consultative Committee, First meeting today

This committee has replaced the now abolished Therapeutic Goods Advertising Code Council. Choice (Australian Consumers’ Association) was a member of previous Code Council (and Complaint Resolution Panel). No doubt the failure of the TGA to invite Choice to this new … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , | Leave a comment

TGA Consultation: Proposed therapeutic goods advertising code guidance

This submission by Alanna Rottler, Mal Vickers and myself  has also has been endorsed by Friends of Science in Medicine. Our previous submissions to TGA consultations have noted that many recommendations made by civil society had been ignored. Most have … Continue reading

Posted in Complementary medicine, Medicine policy, Private Health Insurance | Tagged , , , , , , , , | Leave a comment

APHC 2018 Contested Policy: Complementary Medicines and Advertising Reform

Abstract: PHAA Workshop – Complementary medicine and advertising reform Chair: Ken Harvey Speakers: John Skerritt – Overview of MMD recommendations Alanna Rottler – Pre-approval of certain advertisements to cease Jon Wardle – Permitted indications to replace ARTG ‘free text’ Alanna … Continue reading

Posted in Complementary medicine, Education, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment